dorzolamide hydrochloride - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
COSOPT dorzolamide hydrochloride 20mg and timolol maleate 5mg per mL eye drop bottle
AUST R: 66103
Active ingredients:
dorzolamide hydrochloride
timolol maleate

Dosage form:
Eye Drops, solution

Sponsor:
Mundipharma Pty Ltd

Phone:
1800 188 009

From
05 Aug 2024
to
28 Feb 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Mundipharma has made the decision to reinstate Cosopt eye drops as an ongoing product available in the Australian market. The sponsor is working to expedite the next shipment. Alternative generic products are available.

TRUSOPT dorzolamide 20mg/mL (as hydrochloride) eye drops bottle
AUST R: 55022
Active ingredients:
dorzolamide hydrochloride

Dosage form:
Eye Drops, solution

Sponsor:
Mundipharma Pty Ltd

Phone:
1800 188 009

From
30 Oct 2024
to
28 Feb 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Mundipharma has made the decision to reinstate Trusopt eye drops as an ongoing product available in the Australian market. An alternative generic product is available.

COSOPT PRESERVATIVE-FREE dorzolamide (as hydrochloride) 20mg/mL and timolol (as maleate) 5mg/mL single dose eye drop ampoule
AUST R: 165915
Active ingredients:
dorzolamide hydrochloride
timolol maleate

Dosage form:
Eye Drops, solution

Sponsor:
Mundipharma Pty Ltd

Phone:
1800 188 009

Deletion from market:
31 Jul 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative generic product is available.